Multiple Assemblies exist for SMTL entry 5tcc
Complement Factor D inhibited with JH4; X-RAY DIFFRACTION 3.37 Å

	SMTL ID 5tcc.1 Ligands (2S)-N-(6-bromopyridin-2-yl)-3-[(1H-indazol-1-yl)acetyl]-1,3-thiazolidine-2-carboxamide Polypeptides Complement factor D Oligo-state monomer
	SMTL ID 5tcc.2 Ligands (2S)-N-(6-bromopyridin-2-yl)-3-[(1H-indazol-1-yl)acetyl]-1,3-thiazolidine-2-carboxamide Polypeptides Complement factor D Oligo-state monomer
	SMTL ID 5tcc.3 Ligands (2S)-N-(6-bromopyridin-2-yl)-3-[(1H-indazol-1-yl)acetyl]-1,3-thiazolidine-2-carboxamide Polypeptides Complement factor D Oligo-state monomer
	SMTL ID 5tcc.4 Ligands (2S)-N-(6-bromopyridin-2-yl)-3-[(1H-indazol-1-yl)acetyl]-1,3-thiazolidine-2-carboxamide Polypeptides Complement factor D Oligo-state monomer
	SMTL ID 5tcc.5 Ligands (2S)-N-(6-bromopyridin-2-yl)-3-[(1H-indazol-1-yl)acetyl]-1,3-thiazolidine-2-carboxamide Polypeptides Complement factor D Oligo-state monomer
	SMTL ID 5tcc.6 Ligands (2S)-N-(6-bromopyridin-2-yl)-3-[(1H-indazol-1-yl)acetyl]-1,3-thiazolidine-2-carboxamide Polypeptides Complement factor D Oligo-state monomer
	SMTL ID 5tcc.7 Ligands (2S)-N-(6-bromopyridin-2-yl)-3-[(1H-indazol-1-yl)acetyl]-1,3-thiazolidine-2-carboxamide Polypeptides Complement factor D Oligo-state monomer